[Postheparin plasmatic diamineoxidase (DAO) in chronic liver and kidney diseases (author's transl)].
PLasmatic Diamineoxidase (DAO) was studied after heparin injections i.v. (50 I.U./kg b.w.) in chronic liver and kidney diseases. The DAO increase after heparin is reduced in patients as to controls. Such a reduction may be consequence of DAO discharge in some organs determined by the deliverance of endogenous heparin.
D006631:Amine Oxidase (Copper-Containing) / Q000097:blood*; D002908:Chronic Disease; D006493:Heparin; D006801:Humans; D007674:Kidney Diseases / Q000201:enzymology*; D007700:Kinetics; D008107:Liver Diseases / Q000201:enzymology*
D006493:Heparin; D006631:Amine Oxidase (Copper-Containing)
La diaminossidasi (DAO) posteparinica nelle epatopatie e nefropatie croniche.